欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3923/001
药品名称Pemetrexed Viatris 25 mg/ml concentrate for solution for infusion
活性成分
    • pemetrexed 25.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Viatris Ltd Damastown Industrial Park Mulhuddart Dublin 15 Dublin, Ierland
参考成员国 - 产品名称Netherlands (NL)
Pemetrexed MAH 25 mg/ml concentrate for solution for infusion
互认成员国 - 产品名称
    • Denmark (DK)
    • Germany (DE)
      Pemetrexed Genthon 25 mg/ml Konzentrat zur Hertellung einer Infusionslösung
    • Belgium (BE)
      Pemetrexed Viatris 25 mg/ml concentraat voor oplossing voor infusie
    • Iceland (IS)
      Pemetrexed Genthon 25 mg/ml innrennslisþykkni, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Italy (IT)
    • Greece (GR)
      PEMETREXED/GENTHON
    • Latvia (LV)
      Pemetrexed Mylan 25 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Pemetrexed Mylan 25mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      PEMETREXED VIATRIS
    • Norway (NO)
    • Portugal (PT)
      Pemetrexedo Mylan
    • Malta (MT)
许可日期2017/11/08
最近更新日期2024/03/28
药物ATC编码
    • L01BA04 pemetrexed
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase